ALFA Finder
17:21 IST
NSE
Promoter Reclassification
Anuh Pharma Promoter Reclassification
Anuh Pharma's promoter group member Nina Vijay Shah withdrew her request to reclassify to the public category. She remains in the promoter group.
Anuh Pharma Ltd
- Share price
- ₹83.33
- Market cap
- ₹835.2 Cr
- Revenue (annual)
- ₹771.7 Cr
- Net profit (annual)
- ₹41.05 Cr
- P/E (TTM)
- 17.5×Sector 43.8×
- Promoter holding
- 71.80%+0.00% QoQ
- FII holding
- 0.11%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Promoter Reclassification 1Financial Results 1Debt & Borrowing 1Board Meeting Date 1Acquisition 1
Time
5 announcements with these filters
16:47 IST
NSE
Financial Results
Anuh Pharma Q2 FY27 Results: Net Profit ₹11.2 Cr, Up 47.4% YoY
Anuh Pharma Ltd reported revenue from operations of ₹185.2 Cr (-0.4% YoY) and net profit of ₹11.2 Cr (+47.4% YoY) for Q2 FY27.
- Key figure
- Net profit ₹11.2 Cr · +47.4% YoY
13:17 IST
BSE
Board Meeting Date
Anuh Pharma Board Meeting Date
Anuh Pharma's board meets on 30 October 2026 to approve Q1/H1 FY27 results. Trading window closed for insiders until 1 November 2026.
18:54 IST
BSE
Acquisition
Anuh Pharma Acquisition Worth ₹72.9 Cr
Anuh Pharma signed an Asset Transfer Agreement to acquire a manufacturing facility from Vanquest Pharma for ₹72.90 Crore, increasing its production capacity by 525 MTPA.
- Value
- ₹72.90 Cr
- manufacturing capacity
- 525.0 MTPA
18:37 IST
BSE
Debt & Borrowing
Anuh Pharma Debt & Borrowing: ₹75 Cr
Anuh Pharma Ltd board approved a loan of ₹75 Crore to finance manufacturing asset investments for expanding production capacity.
- Value
- ₹75.00 Cr